Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 169 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| GAPDH | ENSG00000111640 | 0.60 | 0.00 | 1 | 0 |
| SCG2 | ENSG00000171951 | 0.00 | 0.00 | 0 | 0 |
| CDK2 | ENSG00000123374 | 0.00 | 0.00 | 0 | 0 |
| SF3B3 | ENSG00000189091 | 0.28 | 0.16 | 2 | 1 |
| CDC25C | ENSG00000158402 | 0.29 | 0.13 | 1 | 1 |
| PRPF4B | ENSG00000112739 | 0.38 | 0.37 | 2 | 2 |
| MBOAT2 | ENSG00000143797 | 0.16 | 0.15 | 1 | 1 |
| SLC45A3 | ENSG00000158715 | 0.00 | 0.00 | 0 | 0 |
| BCL2L1 | ENSG00000171552 | 3.59 | 0.00 | 10 | 0 |
| TMPRSS2 | ENSG00000184012 | 0.00 | 0.41 | 0 | 1 |
| COL1A2 | ENSG00000164692 | 0.00 | 0.00 | 0 | 0 |
| HNF4A | ENSG00000101076 | 0.36 | 0.00 | 2 | 0 |
| MMP13 | ENSG00000137745 | 0.00 | 0.00 | 0 | 0 |
| MMP11 | ENSG00000099953 | 0.00 | 0.00 | 0 | 0 |
| REV3L | ENSG00000009413 | 0.00 | 0.55 | 0 | 4 |
| MDM2 | ENSG00000135679 | 5.27 | 0.00 | 10 | 0 |
| PSMA6 | ENSG00000100902 | 0.19 | 0.00 | 1 | 0 |
| MYT1 | ENSG00000196132 | 0.15 | 0.00 | 1 | 0 |
| SMARCA2 | ENSG00000080503 | 0.13 | 0.19 | 1 | 1 |
| LCK | ENSG00000182866 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 169 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.